Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan episode artwork

EPISODE · Oct 21, 2025 · 40 MIN

Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan

from Power to the Patients · host Brandon Li

What if you could learn the secrets behind one of psychiatry's most significant breakthroughs in decades? In this episode of Power to the Patients, host Brandon Li sits down with Steve Brannan, Chief Medical Officer of Karuna Therapeutics, to explore the art of clinical trial excellence, the future of precision psychiatry, and the untold story behind developing the first new-mechanism schizophrenia drug in decades. Whether you're a researcher, clinician, or industry professional, this conversation reveals invaluable insights about trial methodology, site relationships, and the delicate balance between speed and quality in drug development. Tune in to discover why clinical operations excellence might be the most underappreciated factor in successful psychiatric drug development.

Episode metadata supplied by the publisher feed · Published Oct 21, 2025

Embed this episode

Ready to play

Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan

0:00 40:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Power to the Patients?

This episode is 40 minutes long.

When was this Power to the Patients episode published?

This episode was published on October 21, 2025.

Can I download this Power to the Patients episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!